Rizatriptan Benzoate
Product Images NDC 54868-6394
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 54868-6394). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Rizatriptan Benzoate Usp Structural Formula (99c66300 Bd75 4b31 9fab 88c6e4b12688 01)
Figure 1: Estimated Probability Of Achieving An Initial Headache Response By 2 Hours In Pooled Studies 1, 2, 3, And 4 (99c66300 Bd75 4b31 9fab 88c6e4b12688 02)
Figure 2: Estimated Probability Of Patients Taking A Second Dose Of Rizatriptan Benzoate Tablets Or Other Medication For Migraines Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Studies 1, 2, 3, And 4 (99c66300 Bd75 4b31 9fab 88c6e4b12688 03)
Glenmark Logo (99c66300 Bd75 4b31 9fab 88c6e4b12688 04)
Glenmark Logo (99c66300 Bd75 4b31 9fab 88c6e4b12688 05)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.